Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;46(8):1616-1625.
doi: 10.1007/s00259-019-04322-7. Epub 2019 Apr 19.

[68Ga]Pentixafor PET/MR imaging of chemokine receptor 4 expression in the human carotid artery

Affiliations

[68Ga]Pentixafor PET/MR imaging of chemokine receptor 4 expression in the human carotid artery

Xiang Li et al. Eur J Nucl Med Mol Imaging. 2019 Jul.

Abstract

Purpose: Type 4 chemokine receptor (CXCR4) plays an important role in immune cell migration during the atherosclerosis progression. We aimed to evaluate [68Ga]Pentixafor positron emission tomography (PET) in combination magnetic resonance imaging (MRI) for in vivo quantification of CXCR4 expression in carotid plaques.

Methods: Seventy-two patients with lymphoma were prospectively scheduled for whole body [68Ga]Pentixafor PET/MRI with an additional T2-weighted carotid sequence. Volumes of interest (VOIs) were drawn along the carotid bifurcation regions, and the maximum tissue-to-blood ratios (TBR) of [68Ga]Pentixafor uptake were calculated. Lesions were categorized into non-eccentric (n = 27), mild eccentric (n = 67), moderately (n = 41) and severely (n = 19) eccentric carotid atherosclerosis. A different cohort of symptomatic patients (n = 10) with carotid stenosis scheduled for thrombendarterectomy (TEA) was separately imaged with 3T MRI with dedicated plaque sequences (time of flight, T1-, and T2-weighted). MRI findings were correlated with histochemical assessment of intact carotid plaques.

Results: At hybrid PET/MRI, we observed significantly increased [68Ga]Pentixafor uptake in mildly (mean TBRmax = 1.57 ± 0.27, mean SUVmax = 2.51 ± 0.39), moderately (mean TBRmax = 1.64 ± 0.37, mean SUVmax = 2.61 ± 0.55) and severely eccentric carotids (mean TBRmax = 1.55 ± 0.26, mean SUVmax = 2.40 ± 0.44) as compared to non-eccentric carotids (mean TBRmax = 1.29 ± 0.21, mean SUVmax = 1.77 ± 0.42) (p ≤ 0.05). Histological findings from TEA confirmed that prominent CXCR4 expression was localized within inflamed atheromas and preatheromas. Co-localization of cellular CXCR4 and CD68 expression in the plaque was observed by immunofluorescence staining.

Conclusions: In vivo evaluation of CXCR4 expression in carotid atherosclerotic lesions is feasible using [68Ga]Pentixafor PET/MRI. In atherosclerotic plaque tissue, CXCR4 expression might be used as a surrogate marker for inflammatory atherosclerosis.

Keywords: Atherosclerosis; CXCR4; Carotid artery; PET/MRI; [68Ga]Pentixafor.

PubMed Disclaimer

Conflict of interest statement

Hans-Jürgen Wester is shareholder of SCINTOMICS GmbH, Germany. SCINTOMICS owns the IP on Pentixafor.

The other enlisted authors have no conflict of interest to declare.

Figures

Fig. 1
Fig. 1
Study flowchart. MALT, mucosa-associated lymphoid tissue; SUV, standardized uptake value; TBR, target to background ratio; TOF, time of flight
Fig. 2
Fig. 2
Example transaxial [68Ga]Pentixafor PET/MRI images of carotid lesions within different groups. Focal uptake was observed in a mildly atherosclerotic carotid artery showing a slightly eccentric thickening (Group 1) and in a moderately (Group 3) and severely (Group 4) atherosclerotic carotid showing significant eccentric thickening, increased tracer uptake was absent at non-significantly eccentric control carotid (Group 1). Arrows indicate the arterial regions of interest
Fig. 3
Fig. 3
a and b [68Ga]Pentixafor uptake ratios (mean of TBRmax and SUVmax) of categorized atherosclerotic lesions. In group 1, non-obstructive carotids (N = 27), uptake was significantly lower (*p < 0.05) compared to group 2 (mildly eccentric carotid atherosclerosis, N = 67), group 3 (moderately eccentric carotid atherosclerosis, N = 41) and group 4 (severely eccentric carotid atherosclerosis, N = 19). There was no significant difference between other groups. c Linear relationship between TBRmax and SUVmax in all lesions (Pearson’s r = 0.72, *p < 0.01). d The percentages (r) of CXCR4+ plaque area/ total plaque area in cross-sections were assessed in categorized carotid lesions as 9.08 ± 0.74% for fibroatheroma (N = 2), 16.95 ± 2.01% for preatheroma (N = 3) and 28.58 ± 3.83% for inflamed atheroma (N = 5). * Significance level of p ≤ 0.05
Fig. 4
Fig. 4
Multi-sequenced MRI of the internal carotid arteries, including time-of-flight (TOF), T1-, and T2-weighted protocols. Corresponding histology (collagen Masson’s Trichrome stain) and immunohistochemistry (CD68 and CXCR4) examination of excised carotid plaques were compared with MRI. Arrows indicate the carotid plaque regions of interests in cross-section views, which were correlated with immunohistochemistry results. Relative lower CD68 expression and CXCR4 expression was observed within fibrous tissue (first column) and increased CXCR4 expression along with increased infiltrated monocytes/macrophages, as indicated by CD68, was detected in preatheroma (second column) during early plaque formation, particularly prominent in atheroma with thin fibrotic cap (third column)
Fig. 5
Fig. 5
Representative immunofluorescence staining of an excised carotid plaque. CXCR4 expression (green) in excised carotid plaque, CD3 staining (left red) for expression of T cells, CD68 staining (left red) for expression of macrophages and nuclear counterstaining with DAPI (blue), 4′,6-diamidino-2-phenylindole. CXCR4 expression was partly co-localized with CD3-positive cells and mostly co-localized with CD68-positive cells

Similar articles

Cited by

References

    1. Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114:1852–1866. doi: 10.1161/CIRCRESAHA.114.302721. - DOI - PubMed
    1. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–e603. doi: 10.1161/CIR.0000000000000485. - DOI - PMC - PubMed
    1. Tarkin JM, Dweck MR, Evans NR, Takx RA, Brown AJ, Tawakol A, et al. Imaging atherosclerosis. Circ Res. 2016;118:750–769. doi: 10.1161/CIRCRESAHA.115.306247. - DOI - PMC - PubMed
    1. Cai JM, Hatsukami TS, Ferguson MS, Small R, Polissar NL, Yuan C. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002;106:1368–1373. doi: 10.1161/01.CIR.0000028591.44554.F9. - DOI - PubMed
    1. Chu B, Kampschulte A, Ferguson MS, Kerwin WS, Yarnykh VL, O’Brien KD, et al. Hemorrhage in the atherosclerotic carotid plaque: a high-resolution MRI study. Stroke. 2004;35:1079–1084. doi: 10.1161/01.STR.0000125856.25309.86. - DOI - PubMed